.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Cantor Fitzgerald
Merck
Accenture
McKesson
Chinese Patent Office
Teva
US Army
Farmers Insurance
Fish and Richardson

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202080

« Back to Dashboard

NDA 202080 describes OXAYDO, which is a drug marketed by Egalet Us Inc and is included in one NDA. It is available from three suppliers. There are six patents protecting this drug. Additional details are available on the OXAYDO profile page.

The generic ingredient in OXAYDO is oxycodone hydrochloride. There are seventeen drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.

Summary for 202080

Tradename:1
Applicant:1
Ingredient:1
Patents:6
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 202080

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 202080

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXAYDO oxycodone hydrochloride TABLET;ORAL 202080 NDA Lake Erie Medical DBA Quality Care Products LLC 55700-447 55700-447-30 30 TABLET in 1 BOTTLE (55700-447-30)
OXAYDO oxycodone hydrochloride TABLET;ORAL 202080 NDA Lake Erie Medical DBA Quality Care Products LLC 55700-448 55700-448-30 30 TABLET in 1 BOTTLE (55700-448-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Jun 17, 2011TE:RLD:No
Patent:► SubscribePatent Expiration:Mar 16, 2025Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Nov 26, 2023Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Nov 26, 2023Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Deloitte
Argus Health
Johnson and Johnson
AstraZeneca
Novartis
Chubb
Baxter
Express Scripts
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot